• Mission

    Spring Bank is devoted to pioneering its revolutionary SMNH chemistry platform to discover and develop a new generation of medicines to improve the lives of patients worldwide.
  • Our Technology

    Our proprietary small molecule nucleic acid hybrids (SMNH) chemistry platform produces a class of compounds designed to selectively target and modulate the activity of specific proteins implicated in various disease states with the favorable drug-like qualities of traditional small molecules.
  • Clinical Trials

    Get the latest information about our ongoing clinical trials.
    Details
  • Latest News

      • JUNE 22, 2017

      Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock

      HOPKINTON, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases, announced today the pricing of its previously announced underwritten public offering of 2,884,615 shares of its common stock at a price to the public of $13.00 per share. Spring Bank’s gross proceeds from this offering are expected to be approximately $37.5 million, before deducting underwriting discounts and commissions and estimated offering expenses.  In addition, Spring Bank has granted the underwriters a 30-day option to purc…

      Read more
      • JUNE 21, 2017

      Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock

      HOPKINTON, Mass., June 21, 2017 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases, announced today that it intends to offer shares of its common stock in an underwritten public offering. Spring Bank also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock offered in the public offering. All of the shares will be offered and sold by Spring Bank. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering ma…

      Read more